Healio

Octreotide in the treatment of chemotherapy-induced diarrhea

Please provide your email address to receive an email when new articles are posted on . Diarrhea in cancer patients is common and can result from different treatments and toxicities. These include ...
Healio

Octreotide Acetate

Octreotide is used to treat severe watery diarrhea and sudden reddening of the face and neck caused by certain types of tumors (such as carcinoid tumors, vasoactive intestinal peptide tumors) that are ...
Monthly Prescribing Reference

First Generic Version of Sandostatin LAR Depot Now Available

The first generic version of Sandostatin ® LAR Depot is now available from Teva Pharmaceuticals. Teva’s Octreotide Acetate for Injectable Suspension is indicated for treatment in patients who have ...
Medindia

Sandostatin (Octreotide) Drug Price and Information

Octreotide (Sandostatin) is a synthetic octapeptide, prescribed for acromegaly. It is also used to control diarrhea and flushing caused by cancer.It decreases the amount of certain natural substances ...
ascopubs.org

A Randomized Trial Evaluating Patient Experience and Preference Between Octreotide Long-Acting Release and Lanreotide for Treatment of Well-Differentiated Neuroendocrine Tumors

Clinical Benefit and Expedited Approval of Cancer Drugs in the United States, European Union, Switzerland, Japan, Canada, and Australia Randomized, single-blinded study. Patients with NETs received ...
Monthly Prescribing Reference

Long-Acting Octreotide Therapy Gets Orphan Drug Status for Polycystic Liver Disease

CAM2029 is an investigational ready-to-use, long-acting octreotide subcutaneous injection depot. Polycystic liver disease is a rare genetic disorder characterized by the progressive growth of more ...
Nasdaq

Camurus announces positive Phase 3 results from the ACROINNOVA 2 study of octreotide SC depot (CAM2029) in acromegaly patients

Treatment well tolerated with a safety profile consistent with standard-of-care (SoC) Increased biochemical response rates (IGF-1≤1xULN) vs SoC at baseline Continuous improvement of acromegaly symptom ...
Medindia

Sandostatin (0.1 mg) (Octreotide) Drug Price and Information

Octreotide (Sandostatin (0.1 mg)) is a synthetic octapeptide, prescribed for acromegaly. It is also used to control diarrhea and flushing caused by cancer.It decreases the amount of certain natural ...
Drug Store News

Teva intros generic Sandostatin LAR Depot

Teva is introducing the only generic version of Novartis AG's Sandostatin LAR Depot, in the United States. Octreotide acetate for injectable suspension is indicated to treat acromegaly and severe ...
Nasdaq

Teva Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.

PARSIPPANY, N.J., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of the first and ...
The New England Journal of Medicine

Octreotide Therapy for Tumor-Induced Osteomalacia

We describe an adult man who had hypophosphatemic osteomalacia for several years before an octreotide scan revealed a mesenchymal tumor in his left thigh. Moreover, subcutaneous administration of ...
Yahoo Finance

Viatris Gets FDA Nod for Generic Sandostatin, Shares Regulatory Updates

Viatris Inc. VTRS recently announced four regulatory achievements across multiple stages of its pipeline. These achievements outline the company’s R&D progress in 2025. VTRS will continuously work ...